Amgen Inc.AMGNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank36
3Y CAGR-2.7%
5Y CAGR-3.9%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
-2.7%/yr
vs -4.5%/yr prior
5Y CAGR
-3.9%/yr
Consistent
Acceleration
+1.8pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.10B | -22.1% |
| 2024 | $10.39B | +41.2% |
| 2023 | $7.36B | -16.2% |
| 2022 | $8.79B | +4.8% |
| 2021 | $8.38B | -15.2% |
| 2020 | $9.89B | +15.9% |
| 2019 | $8.53B | -19.2% |
| 2018 | $10.56B | +0.4% |
| 2017 | $10.51B | +10.5% |
| 2016 | $9.52B | - |